Teva Pharmaceutical Industries (TEVA) Liabilities from Discontinued Operations (2017)
Teva Pharmaceutical Industries (TEVA) recorded quarterly Liabilities from Discontinued Operations of 38000000.0 in Q4 2017.
Teva Pharmaceutical Industries (TEVA) Liabilities from Discontinued Operations (2017) Analysis & Trends
Teva Pharmaceutical Industries has disclosed Liabilities from Discontinued Operations across 1 years of filings, most recently posting 38000000.0 for Q4 2017.
- Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 38000000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was 38000000.0 (changed N/A YoY) and the FY2017 annual result came in at 38000000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations steadied at 38000000.0 in Q4 2017.
- Over five years, Liabilities from Discontinued Operations peaked at 38000000.0 in Q4 2017 and troughed at 38000000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 38.00 Mn |
| Dec 31, 2017 | 38.00 Mn |